APOBEC3B and breast neoplasm: Very recently, Burns et al. provided evidence that APOBEC3B is overexpressed in breast cancer tumors and cell lines and that the APOBEC3B mutation signature is statistically more prevalent in the breast tumor database of The Cancer Genome Atlas (TCGA) than is expected [47].